{"id":"W2592509339","doi":"10.1111/epi.13709","title":"<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology","year":2017,"lang":"en","type":"article","venue":"Epilepsia","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":4881,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; BC Children's Hospital; University of British Columbia","funders":"Cilag; UCB Pharma; National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; University of California, Los Angeles; Sun Pharma; Universidade Católica de Brasília; Fundação Bial; Eisai; Epilepsy Research UK; NeuroPace; National Institutes of Health; Mylan; Supernus Pharmaceuticals; Zynerba Pharmaceuticals; Upsher-Smith; Division of Arctic Sciences; Sage Therapeutics; Epilepsiatutkimussäätiö; Dravet Syndrome UK; Zogenix; Alva Foundation; Lundbeckfonden; U.S. Department of Defense; Yorkhill Children’s Charity; GW Pharmaceuticals; Sanofi; Citizens United for Research in Epilepsy; Novartis; Acorda Therapeutics; Stockholms Läns Landsting; Takeda Pharmaceuticals U.S.A.; Pfizer; Humanities Research Center, Rice University; Ultragenyx Pharmaceutical; GlaxoSmithKline; Vertex Pharmaceuticals; March of Dimes Foundation; National Institute of Neurological Disorders and Stroke; CURE Childhood Cancer; H. Lundbeck A/S; Sunovion","keywords":"Epilepsy; Terminology; Etiology; Medicine; Epilepsy syndromes; Generalized epilepsy; Pediatrics; Intensive care medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01130019,0.001351338,0.001756194,0.006292293,0.002538379,0.007376499,0.003345604,0.004219119,0.03102571],"category_scores_gemma":[0.04951713,0.0005057158,0.00205403,0.00741146,0.003447291,0.005217645,0.003762607,0.008890629,0.0364991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008391358,"about_ca_system_score_gemma":0.02884939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03904691,"about_ca_topic_score_gemma":0.04079654,"domain_scores_codex":[0.9851811,0.002361919,0.0029399,0.0007375213,0.007621467,0.001158122],"domain_scores_gemma":[0.9449277,0.006736144,0.004875165,0.00199363,0.03904883,0.002418555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001864517,0.000006593663,0.00028564,0.0002237797,0.000005715991,0.00003836659,0.00008680744,0.00003164421,0.00008618629,0.004133762,0.9777614,0.01732142],"study_design_scores_gemma":[0.00001809297,0.00001488331,0.002048914,0.001361248,0.00001354324,0.0002984345,0.0002190199,0.0000755504,0.0001992816,0.004007713,0.9917134,0.00002998568],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.002771288,0.06565521,0.01645476,0.4200945,0.1927688,0.002043023,0.03858313,0.001484317,0.260145],"genre_scores_gemma":[0.04449468,0.1156206,0.06573151,0.2250587,0.1087567,0.006148958,0.1678557,0.004697119,0.2616361],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.03904691,"threshold_uncertainty_score":0.1037914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04828185098861416,"score_gpt":0.3252588484545615,"score_spread":0.2769769974659473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}